Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance. [electronic resource]
Producer: 20111017Description: 424-31 p. digitalISSN:- 1365-2036
- Adenine -- analogs & derivatives
- Adolescent
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- China
- Drug Resistance, Viral -- drug effects
- Drug Therapy, Combination
- Female
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Organophosphonates -- therapeutic use
- Polyethylene Glycols -- therapeutic use
- Recombinant Proteins
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.